GlassScriptPhysician profile
Mehrdad Razavi
NPI 1609857788
$853.37
in general payments reported to CMS, 2019-2025
8 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Sleep Medicine (Psychiatry & Neurology) provider received nationally (typical 2025 total: $337).
See the full distribution for Sleep Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $102 · 2021: $37.15 · 2022: $81.13 · 2023: $288 · 2024: $47.98 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $515.85 | 2019-2025 | Lab Traditional Nasal, (Ad1) Nasal Masks - Traditional, Full Face Masks - Over The Head |
| Harmony Biosciences LLC | $115.42 | 2023 | Wakix |
| 3b Medical, INC. | $74.79 | 2023 | Luna |
| Akcea Therapeutics, INC. | $40.78 | 2020 | |
| Resmed Corp | $35.88 | 2020 | |
| Jazz Pharmaceuticals INC. | $34.81 | 2023 | |
| Axsome Therapeutics, INC. | $20.37 | 2023 | Sunosi |
| Fisher & Paykel Healthcare INC | $15.47 | 2025 | Fisher & Paykel Healthcare |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehrdad Razavi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.